Journal of Comparative Effectiveness Research, 2023 Aim: Durability of aortic valve replacement is becoming increasingly important. Aortic bioprostheses with RESILIA tissue have demonstrated outstanding outcomes thus far, but only in single-arm studies.
Krzysztof Bartus +4 more
doaj +3 more sources
Structural valve deterioration of bioprosthetic aortic valves: An underestimated complication [PDF]
Journal of Thoracic and Cardiovascular Surgery, 2019 Structural valve deterioration (SVD) remains a major bioprosthesis-related complication, as recently described for the Mitroflow valve (models LX and 12A) (LivaNova, London, United Kingdom). The real incidence of the SVD risk remains unclear, often due to methodologic pitfalls by systematically using the Kaplan-Meier estimator and/or the Cox model.
Yohann Foucher, Jean Christian Roussel
exaly +6 more sources
Early Structural Valve Deterioration and Cusp Tear Leading to Acute Heart Failure in a Second-Generation Trifecta Glide Technology Heart Valve [PDF]
Texas Heart Institute JournalThis report highlights a case of early structural valve deterioration with a cusp tear in a second-generation Abbott Trifecta Glide Technology bioprosthetic heart valve.
Akiyoshi Yamamoto, MD +3 more
doaj +3 more sources
Structural deterioration of the cryopreserved mitral homograft valve [PDF]
The Journal of Thoracic and Cardiovascular Surgery, 2012 The aim of this study was to evaluate the long-term fate of the cryopreserved mitral homograft focusing on structural valve deterioration.Homograft replacement of the mitral valve was performed in 106 patients. The causes of mitral disease were rheumatic disease (n=75), endocarditis (n=24), and others (n=7).
Olivito, Silvio +6 more
openaire +4 more sources
Tricuspid Structural Valve Deterioration Treated with a Transcatheter Valve-in-Valve Implantation: A Single-Center Prospective Registry [PDF]
Journal of Clinical Medicine, 2022 The valve-in-valve (ViV) technique is an emerging alternative for the treatment of bioprosthetic structural valve deterioration (SVD) in the tricuspid position. We report on the outcomes of patients treated by a transcatheter tricuspid valve-in-valve (TT-
Alexander Sagie +2 more
exaly +3 more sources
Vitamin K antagonists and structural valve deterioration in bioprosthetic aortic valves. [PDF]
Turk Gogus Kalp Damar Cerrahisi DergTo evaluate the effect of postoperative vitamin K antagonist (VKA) exposure on structural valve deterioration (SVD) after bioprosthetic aortic valve replacement (AVR).We retrospectively analysed 123 patients who underwent surgical bioprosthetic AVR between 2010 and 2025 with adequate echocardiographic follow-up.
Dayanır OB +5 more
europepmc +4 more sources
Evaluation of incidence of structural valve deterioration in patients with Freestyle aortic valve [PDF]
Minia Journal of Medical Research, 2023 Background: The Freestyle aortic root bio prosthesis is a complete porcine aortic root implanted by different techniques: sub coronary, root inclusion, or complete aortic root replacement.
Areej Muhammad +3 more
doaj +2 more sources
Redo aortic valve replacement due to early structural valve deterioration in a trifecta valve: A case report. [PDF]
Int J Surg Case Rep, 2021 Abstract Introduction and importance While the number of SAVR cases has been increasing for patients below their sixties due to the improvement of bioprosthetic valves, some early structural valve deterioration (SVD) in Trifecta valves has been reported.
Watanabe T +4 more
europepmc +3 more sources
Transcatheter Aortic Valve-in-Valve Procedure in Patients with Bioprosthetic Structural Valve Deterioration. [PDF]
Methodist Debakey Cardiovasc J, 2017 Surgical aortic valve replacement is the gold standard procedure to treat patients with severe, symptomatic aortic valve stenosis or insufficiency. Bioprosthetic valves are used for surgical aortic valve replacement with a much greater prevalence than mechanical valves.
Reul RM, Ramchandani MK, Reardon MJ.
europepmc +4 more sources
Implanted size and structural valve deterioration in the Edwards Magna bioprosthesis. [PDF]
Ann Cardiothorac SurgThe desire of patients to avoid anticoagulation, together with the potential of valve-in-valve (VIV) transcatheter aortic valve replacement (TAVR), have resulted in the increasing use of bioprosthetic valves for aortic valve replacement (AVR). While patient-prosthesis mismatch (PPM) is known to be an adverse risk after AVR, few studies have addressed ...
Johnston DR +9 more
europepmc +3 more sources